Emerald Health Therapeutics Inc
F:TBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Emerald Health Therapeutics Inc
PP&E Net
Emerald Health Therapeutics Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Emerald Health Therapeutics Inc
F:TBD
|
PP&E Net
CA$17.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
PP&E Net
$2.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
PP&E Net
CA$285m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
21%
|
|
|
Cronos Group Inc
TSX:CRON
|
PP&E Net
$147.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
54%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
PP&E Net
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
PP&E Net
CA$21.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Emerald Health Therapeutics Inc
Glance View
Emerald Health Therapeutics, Inc. operates as a cannabis company. The company is headquartered in Vancouver, British Columbia and currently employs 110 full-time employees. The firm's segments include Cannabis and Other. The company primarily operates in the Cannabis segment. The company provides recreational, medical and wellness-oriented cannabis products. The company offers products through brands, including SYNC Wellness, Fuse, whole-flower cannabis, Souvenir and Health Therapeutics. Its SYNC Wellness products include nanoemulsions and cannabis oils. Its Fuse product include nanoemulsion shots. Its whole-flower cannabis products consist of dried cannabis and pre-rolled cannabis. Its Souvenir product is dried flower, which is hang-dried and hand-packaged to optimize terpene profiles. Its Health Therapeutics offers medical products. Its subsidiaries include Emerald Health Therapeutics Canada Inc., Emerald Health Naturals Inc., Avalite Sciences Inc., Verdelite Sciences Inc., and Verdelite Property Holdings Inc.
See Also
What is Emerald Health Therapeutics Inc's PP&E Net?
PP&E Net
17.6m
CAD
Based on the financial report for Dec 31, 2021, Emerald Health Therapeutics Inc's PP&E Net amounts to 17.6m CAD.
What is Emerald Health Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
102%
Over the last year, the PP&E Net growth was -56%. The average annual PP&E Net growth rates for Emerald Health Therapeutics Inc have been -14% over the past three years , 102% over the past five years .
